In Epicured’s recent Partners in Health Women in GI Symposium, Commonwealth Diagnostics International, (CDI) had the privilege of sponsoring a presentation on SIBO vs IBS-D by Judy Nee, MD. During the presentation, Dr. Nee discussed the differences between SIBO and IBS-D and why it is important for physicians to diagnose and treat patients properly.
Watch Dr. Nee’s presentation here:
About Judy Nee, MD:
Judy Nee, MD is a gastroenterologist at Beth Israel Deaconess Medical Center and an assistant professor at Harvard Medical School. She serves as co-director of the GI Motility Lab at Beth Israel. She specializes in GI motility disorders and functional GI diseases such as irritable bowel syndrome, chronic diarrhea, constipation as well as movement disorders of esophagus.
About Commonwealth Diagnostics International:
CDI is an innovative GI health company that provides industry leading diagnostic tools to help physicians identify, diagnose and treat some of the most common sources of digestive distress and functional gastrointestinal ailments in the world. CDI is the only medical diagnostics company that meets the American College of Gastroenterology’s Clinical Guidelines for SIBO as well as the North American Consensus for hydrogen and methane-based breath testing in gastrointestinal disorders. Learn more about our non-invasive at-home hydrogen and methane breath testing for SIBO/IMO as well as IBSchek®, proprietary at-home capillary collection kit for IBS-D/M.
